Abstract
Вплив блокаторів ренінангіотензинової системи на перебіг гіпертонічної хвороби з цукровим діабетом 2 типу та рівні апеліну та ангіотензину 1-7
Highlights
The purpose of the study was to investigate the effects of combined treatment with olmesartan or ramipril
The levels of apelin were significantly increased from 0,871(0,84;0,924
The levels of angiotesin 1-7 were significantly increased in patients who received olmesartan
Summary
The purpose of the study was to investigate the effects of combined treatment with olmesartan or ramipril on the background of providing lercanidipine and lipid-lowering and antidiabetic therapy on the course of hypertensive disease (HD) with type 2 diabetes (T2D) and blood levels of apelin and angiotensin 1-7
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
